| Product Code: ETC10939556 | Publication Date: Apr 2025 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
During 2020-2024, the Gambia vaccine market experienced a significant increase in imports, with a Compound Annual Growth Rate (CAGR) of 767.47%. This growth trend was consistent throughout the period, resulting in a substantial rise in the overall import volume.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Gambia Vaccine Market Overview |
3.1 Gambia Country Macro Economic Indicators |
3.2 Gambia Vaccine Market Revenues & Volume, 2022 & 2032F |
3.3 Gambia Vaccine Market - Industry Life Cycle |
3.4 Gambia Vaccine Market - Porter's Five Forces |
3.5 Gambia Vaccine Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Gambia Vaccine Market Revenues & Volume Share, By Disease Indication, 2022 & 2032F |
3.7 Gambia Vaccine Market Revenues & Volume Share, By Age Group, 2022 & 2032F |
3.8 Gambia Vaccine Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.9 Gambia Vaccine Market Revenues & Volume Share, By Technology, 2022 & 2032F |
4 Gambia Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Government initiatives and funding for vaccination programs |
4.2.2 Increasing awareness and importance of vaccination among the population |
4.2.3 Growing prevalence of infectious diseases in Gambia |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in remote areas |
4.3.2 Vaccine storage and transportation challenges |
4.3.3 High cost associated with vaccine procurement and distribution |
5 Gambia Vaccine Market Trends |
6 Gambia Vaccine Market, By Types |
6.1 Gambia Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Gambia Vaccine Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Gambia Vaccine Market Revenues & Volume, By Preventive Vaccines, 2022 - 2032F |
6.1.4 Gambia Vaccine Market Revenues & Volume, By Therapeutic Vaccines, 2022 - 2032F |
6.1.5 Gambia Vaccine Market Revenues & Volume, By DNA Vaccines, 2022 - 2032F |
6.2 Gambia Vaccine Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Gambia Vaccine Market Revenues & Volume, By Influenza, 2022 - 2032F |
6.2.3 Gambia Vaccine Market Revenues & Volume, By COVID19, 2022 - 2032F |
6.2.4 Gambia Vaccine Market Revenues & Volume, By Hepatitis B, 2022 - 2032F |
6.3 Gambia Vaccine Market, By Age Group |
6.3.1 Overview and Analysis |
6.3.2 Gambia Vaccine Market Revenues & Volume, By Pediatrics, 2022 - 2032F |
6.3.3 Gambia Vaccine Market Revenues & Volume, By Adults, 2022 - 2032F |
6.3.4 Gambia Vaccine Market Revenues & Volume, By Geriatrics, 2022 - 2032F |
6.4 Gambia Vaccine Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Gambia Vaccine Market Revenues & Volume, By Intramuscular, 2022 - 2032F |
6.4.3 Gambia Vaccine Market Revenues & Volume, By Subcutaneous, 2022 - 2032F |
6.4.4 Gambia Vaccine Market Revenues & Volume, By Oral, 2022 - 2032F |
6.5 Gambia Vaccine Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 Gambia Vaccine Market Revenues & Volume, By mRNAbased, 2022 - 2032F |
6.5.3 Gambia Vaccine Market Revenues & Volume, By Viral Vector, 2022 - 2032F |
6.5.4 Gambia Vaccine Market Revenues & Volume, By Protein Subunit, 2022 - 2032F |
7 Gambia Vaccine Market Import-Export Trade Statistics |
7.1 Gambia Vaccine Market Export to Major Countries |
7.2 Gambia Vaccine Market Imports from Major Countries |
8 Gambia Vaccine Market Key Performance Indicators |
8.1 Immunization coverage rate |
8.2 Number of vaccination campaigns conducted |
8.3 Vaccine wastage rate |
8.4 Adverse events following immunization rate |
8.5 Public perception and acceptance of vaccines |
9 Gambia Vaccine Market - Opportunity Assessment |
9.1 Gambia Vaccine Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Gambia Vaccine Market Opportunity Assessment, By Disease Indication, 2022 & 2032F |
9.3 Gambia Vaccine Market Opportunity Assessment, By Age Group, 2022 & 2032F |
9.4 Gambia Vaccine Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.5 Gambia Vaccine Market Opportunity Assessment, By Technology, 2022 & 2032F |
10 Gambia Vaccine Market - Competitive Landscape |
10.1 Gambia Vaccine Market Revenue Share, By Companies, 2025 |
10.2 Gambia Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here